Skip to main content
OB

Orange Biomed

Orange Biomed has developed the OBM rapid A1c at-home testing system, which utilizes microfluidic technology to deliver lab-accurate A1C results from a single drop of blood in just five minutes. This device addresses the issue of inaccurate A1C measurements in diverse patient populations, enabling timely diabetes management and preventive care.

Hillsborough, United StatesFounded 20219500+ followers
Updated 4 months ago

Funding

$6.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current A1C testing methods can be inconvenient, requiring lab visits or point-of-care devices that may lack accuracy, particularly across diverse patient populations. Delays in obtaining accurate A1C measurements can hinder timely adjustments to diabetes management plans and delay preventive care. Existing point-of-care solutions may also exhibit interference from hemoglobin variants, leading to inaccurate results for individuals with African, Asian, and Mediterranean ancestry.

Solution

Orange Biomed's OBM rapid A1c At-Home System enables individuals and clinics to conduct lab-accurate A1C tests using a single drop of blood, with results available in five minutes. The system utilizes microfluidic technology to eliminate interference from hemoglobin variants, ensuring accurate measurements across diverse patient populations. The reusable meter does not require re-calibration, and the test kits have a long shelf life without needing refrigeration. This allows for convenient and routine A1C testing, facilitating earlier preventive action and better long-term diabetes management.

Target Audience

The primary target audience includes individuals with diabetes seeking convenient and accurate at-home A1C monitoring, as well as clinics and healthcare providers aiming to improve point-of-care testing accuracy and efficiency.

Features

  • Lab-accurate A1C results in 5 minutes from a single 0.005ml drop of blood.
  • Microfluidic technology eliminates hemoglobin variant interference.
  • Reusable meter that does not require re-calibration.
  • Test kits with a 24-month shelf life and no refrigeration requirements.
  • Fully guided system for easy at-home or point-of-care testing.
  • Portable meter design for convenient use in various clinical settings.
This profile is AI-generated and may contain inaccuracies.